{"id":"n_yfptoalzzezhdz3wkp7a","seq":9321823,"kind":"article","title":"FDA arah pengeluar ubat GLP-1 tambah amaran risiko gangguan penglihatan","url":"https://www.bharian.com.my/dunia/lain-lain/2026/11/1707330/fda-arah-pengeluar-ubat-glp-1-tambah-amaran-risiko-gangguan","summary":"LOS ANGELES: Pentadbiran Makanan dan Ubat-ubatan Amerika Syarikat (FDA) pada Isnin mengarahkan pengeluar semua ubat agonis reseptor ‘glucagon-like peptide-1’ (GLP-1) mengemas kini label keselamatan produk masing-masing, lapor Xinhua.","published":"2026-11-10T05:44:00Z","seen":"2026-11-10T05:44:00Z","lang":"en","country":"MY","source":{"id":"kite-bharian-com-my-f45d9a","name":"bharian.com.my","domain":"bharian.com.my"},"via":"kite-bharian-com-my-f45d9a","topics":["lain-lain (dunia)"],"authors":["AGENSI"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"image":"https://assets.bharian.com.my/images/articles/BH10UBAK-O_BHfield_image_listing_featured_v2.var_1794286924.jpg","story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.71,"sentiment":"negative","tone":-0.62,"political":0.12}